| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.19 | 4e-05 |